GEOVAX LABS INC
GOVX · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $0.28
- Today’s Low
- $0.26
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.30
- Previous Close
- $0.28
- Volume
- 204.85K
- Market Cap
- $2.85M
- P/E Ratio
- --
- EPS
- $-13.92
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1955 LAKE PARK DRIVE, SMYRNA, GA, UNITED STATES, 30080
- Country
- US
- Listing Date
- 1994-04-04
- Fiscal Year End
- December
- Shares Outstanding
- 7.37M
- CIK
- 0000832489
- Website
- www.geovax.com
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$4.44M
2026-03-31
$1.36M
2025-12-31
$4.44M
2025-09-30
$1.32M
Net Income
2026-06-30
-$4.42M
2026-03-31
-$5.26M
2025-12-31
-$4.41M
2025-09-30
-$6.31M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.97
2026-03-31
$-2.62
2025-12-31
--
2025-09-30
$-7.75
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.43M
2026-03-31
-$5.24M
2025-12-31
-$4.4M
2025-09-30
-$6.3M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $4.44M | $1.36M | $4.44M | $1.32M |
| Net Income | -$4.42M | -$5.26M | -$4.41M | -$6.31M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.97 | $-2.62 | -- | $-7.75 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.43M | -$5.24M | -$4.4M | -$6.3M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.